2025 annual financial data

Neuphoria Therapeutics 2025 Operating margin

Direct answer

Operating margin was -7.21%.

Operating income was -1.13M USD and net income was -369,632 USD.
Operating cash flow was 77.23M USD.

Get free Neuphoria Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
15.65M USD
Operating income
-1.13M USD
Net income
-369,632 USD
Operating cash flow
77.23M USD